137 related articles for article (PubMed ID: 24136236)
1. Shape design of high drug payload nanoparticles for more effective cancer therapy.
Li W; Zhang X; Hao X; Jie J; Tian B; Zhang X
Chem Commun (Camb); 2013 Dec; 49(93):10989-91. PubMed ID: 24136236
[TBL] [Abstract][Full Text] [Related]
2. Smart nanorods for highly effective cancer theranostic applications.
Yang Y; Zhang X; Yu C; Hao X; Jie J; Zhou M; Zhang X
Adv Healthc Mater; 2014 Jun; 3(6):906-15. PubMed ID: 24376098
[TBL] [Abstract][Full Text] [Related]
3. Novel anti-tumor strategy: PEG-hydroxycamptothecin conjugate loaded transferrin-PEG-nanoparticles.
Hong M; Zhu S; Jiang Y; Tang G; Sun C; Fang C; Shi B; Pei Y
J Control Release; 2010 Jan; 141(1):22-9. PubMed ID: 19735683
[TBL] [Abstract][Full Text] [Related]
4. Amphiphilic Hybrid Dendritic-Linear Molecules as Nanocarriers for Shape-Dependent Antitumor Drug Delivery.
Guo Y; Wang T; Zhao S; Han M; Dong Z; Wang X; Wang Y
Mol Pharm; 2018 Jul; 15(7):2665-2673. PubMed ID: 29782803
[TBL] [Abstract][Full Text] [Related]
5. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.
Min KH; Park K; Kim YS; Bae SM; Lee S; Jo HG; Park RW; Kim IS; Jeong SY; Kim K; Kwon IC
J Control Release; 2008 May; 127(3):208-18. PubMed ID: 18336946
[TBL] [Abstract][Full Text] [Related]
6. PEGylated poly(trimethylene carbonate) nanoparticles loaded with paclitaxel for the treatment of advanced glioma: in vitro and in vivo evaluation.
Jiang X; Xin H; Sha X; Gu J; Jiang Y; Law K; Chen Y; Chen L; Wang X; Fang X
Int J Pharm; 2011 Nov; 420(2):385-94. PubMed ID: 21920419
[TBL] [Abstract][Full Text] [Related]
7. A novel self-assembled nanoparticle platform based on pectin-eight-arm polyethylene glycol-drug conjugates for co-delivery of anticancer drugs.
Liu Y; Liu K; Li X; Xiao S; Zheng D; Zhu P; Li C; Liu J; He J; Lei J; Wang L
Mater Sci Eng C Mater Biol Appl; 2018 May; 86():28-41. PubMed ID: 29525094
[TBL] [Abstract][Full Text] [Related]
8. Molecularly precise dendrimer-drug conjugates with tunable drug release for cancer therapy.
Zhou Z; Ma X; Murphy CJ; Jin E; Sun Q; Shen Y; Van Kirk EA; Murdoch WJ
Angew Chem Int Ed Engl; 2014 Oct; 53(41):10949-55. PubMed ID: 25155439
[TBL] [Abstract][Full Text] [Related]
9. Enhanced anti-glioblastoma efficacy by PTX-loaded PEGylated poly(ɛ-caprolactone) nanoparticles: In vitro and in vivo evaluation.
Xin H; Chen L; Gu J; Ren X; Wei Z; Luo J; Chen Y; Jiang X; Sha X; Fang X
Int J Pharm; 2010 Dec; 402(1-2):238-47. PubMed ID: 20934500
[TBL] [Abstract][Full Text] [Related]
10. Preclinical to clinical development of the novel camptothecin nanopharmaceutical CRLX101.
Svenson S; Wolfgang M; Hwang J; Ryan J; Eliasof S
J Control Release; 2011 Jul; 153(1):49-55. PubMed ID: 21406204
[TBL] [Abstract][Full Text] [Related]
11. Linear-dendritic drug conjugates forming long-circulating nanorods for cancer-drug delivery.
Zhou Z; Ma X; Jin E; Tang J; Sui M; Shen Y; Van Kirk EA; Murdoch WJ; Radosz M
Biomaterials; 2013 Jul; 34(22):5722-35. PubMed ID: 23639529
[TBL] [Abstract][Full Text] [Related]
12. Ketal containing amphiphilic block copolymer micelles as pH-sensitive drug carriers.
Lee I; Park M; Kim Y; Hwang O; Khang G; Lee D
Int J Pharm; 2013 May; 448(1):259-66. PubMed ID: 23524123
[TBL] [Abstract][Full Text] [Related]
13. Carrier-free, functionalized drug nanoparticles for targeted drug delivery.
Li W; Yang Y; Wang C; Liu Z; Zhang X; An F; Diao X; Hao X; Zhang X
Chem Commun (Camb); 2012 Aug; 48(65):8120-2. PubMed ID: 22766919
[TBL] [Abstract][Full Text] [Related]
14. Effect of octreotide surface density on receptor-mediated endocytosis in vitro and anticancer efficacy of modified nanocarrier in vivo after optimization.
Su Z; Shi Y; Xiao Y; Sun M; Ping Q; Zong L; Li S; Niu J; Huang A; You W; Chen Y; Chen X; Fei J; Tian J
Int J Pharm; 2013 Apr; 447(1-2):281-92. PubMed ID: 23396258
[TBL] [Abstract][Full Text] [Related]
15. Effect of PEG conformation and particle size on the cellular uptake efficiency of nanoparticles with the HepG2 cells.
Hu Y; Xie J; Tong YW; Wang CH
J Control Release; 2007 Mar; 118(1):7-17. PubMed ID: 17241684
[TBL] [Abstract][Full Text] [Related]
16. Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation.
Danhier F; Lecouturier N; Vroman B; Jérôme C; Marchand-Brynaert J; Feron O; Préat V
J Control Release; 2009 Jan; 133(1):11-7. PubMed ID: 18950666
[TBL] [Abstract][Full Text] [Related]
17. Brain delivery of camptothecin by means of solid lipid nanoparticles: formulation design, in vitro and in vivo studies.
Martins S; Tho I; Reimold I; Fricker G; Souto E; Ferreira D; Brandl M
Int J Pharm; 2012 Dec; 439(1-2):49-62. PubMed ID: 23046667
[TBL] [Abstract][Full Text] [Related]
18. Probing a dipeptide-based supramolecular assembly as an efficient camptothecin delivering carrier for cancer therapy: computational simulations and experimental validations.
Sun M; Zhang X; Gao Z; Liu T; Luo C; Zhao Y; Liu Y; He Z; Wang J; Sun J
Nanoscale; 2019 Feb; 11(9):3864-3876. PubMed ID: 30758022
[TBL] [Abstract][Full Text] [Related]
19. Development of a novel biocompatible poly(ethylene glycol)-block-poly(γ-cholesterol-L-glutamate) as hydrophobic drug carrier.
Ma Q; Li B; Yu Y; Zhang Y; Wu Y; Ren W; Zheng Y; He J; Xie Y; Song X; He G
Int J Pharm; 2013 Mar; 445(1-2):88-92. PubMed ID: 23376505
[TBL] [Abstract][Full Text] [Related]
20. Characterization and preparation of core-shell type nanoparticle for encapsulation of anticancer drug.
Jang MK; Jeong YI; Nah JW
Colloids Surf B Biointerfaces; 2010 Dec; 81(2):530-6. PubMed ID: 20801624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
